AGR2 and pancreatitis: AG1478-treated AGR2+/- heterozygotes with pancreatitis also exhibited significantly reduced nuclear EGR1 compared to AG1478-untreated heterozygotes, but MKI67 was not significantly affected (Fig 5B and 5C).